Sowyrda
Paul Sowyrda, Needham, MA US
Patent application number | Description | Published |
---|---|---|
20090275932 | LASER ENERGY DEVICES AND METHODS FOR SOFT TISSUE REMOVAL - A laser energy soft tissue aspiration device comprises a cannula defining an aspiration lumen and having one or more aspiration inlet ports at a distal end. A laser energy transmission guide delivers laser energy from the proximal end of the cannula to the distal end which can be inserted to a tissue removal site within a patient. Reciprocating longitudinal motion of the cannula along with suction provided within the lumen can cause soft tissue to be suctioned into the lumen for removal. Laser energy contained within the lumen and directed by an optical delivery system can ablate soft tissue pulled within the lumen. The optical delivery system can further protect the terminal point of the laser energy transmission guide, from which, the laser energy can be delivered. | 11-05-2009 |
20090275933 | LASER ENERGY DEVICES AND METHODS FOR SOFT TISSUE REMOVAL - A laser energy soft tissue aspiration device comprises a cannula defining an aspiration lumen and having one or more aspiration inlet ports at a distal end. A laser energy transmission guide delivers laser energy from the proximal end of the cannula to the distal end which can be inserted to a tissue removal site within a patient. Reciprocating longitudinal motion of the cannula along with suction provided within the lumen can cause soft tissue to be suctioned into the lumen for removal. Laser energy contained within the lumen and directed by an optical delivery system can ablate soft tissue pulled within the lumen. The optical delivery system can further protect the terminal point of the laser energy transmission guide by isolating it, or removing it from the flow of aspirated tissue. | 11-05-2009 |
20090287196 | LASER ENERGY DEVICES AND METHODS FOR SOFT TISSUE REMOVAL - A laser energy soft tissue aspiration device comprises a cannula defining an aspiration lumen and having one or more aspiration inlet ports at a distal end. A laser energy transmission guide delivers laser energy from the proximal end of the cannula to the distal end which can be inserted to a tissue removal site within a patient. Reciprocating longitudinal motion of the cannula along with suction provided within the lumen can cause soft tissue to be suctioned into the lumen for removal. Laser energy contained within the lumen and directed by an optical delivery system can ablate soft tissue pulled within the lumen. The optical delivery system can further protect the terminal point of the laser energy transmission guide, from which, the laser energy can be delivered. | 11-19-2009 |
Paul Sowyrda, Medfield, MA US
Patent application number | Description | Published |
---|---|---|
20090192071 | USE OF PHOTODYNAMIC THERAPY TO ENHANCE TREATMENT WITH IMMUNO-MODULATING AGENTS - Methods of enhancing the efficacy and safety of treatment with immuno-modulating agents are provided. The inventive methods combine treatment with immuno-modulating agents with photodynamic therapy (PDT). PDT can be administered before, during or after administration of the immuno-modulating agent. Combination therapy achieves at least the same efficacy as immuno-modulatory therapy in less time, with less immuno-modulating agent and fewer side-effects. | 07-30-2009 |
20140017182 | Topical Formulations Comprising DNA Repair Enzymes, and Methods of Use Thereof - Disclosed are methods of decreasing or preventing UV-induced skin damage, comprising the step of applying to an area of skin an effective amount of a topical formulation comprising a photolyase and an endonuclease. In certain embodiments, the formulation is applied before and after UV exposure. | 01-16-2014 |
Paul A. Sowyrda, Medfield, MA US
Patent application number | Description | Published |
---|---|---|
20160106654 | ADDITIVE OR SYNERGISTIC SUNSCREEN, ANTIOXIDANT, AND DNA REPAIR ENZYME COMPOSITION - A composition having an sunscreen agent, an antioxidant, and a DNA repair enzyme provides a beneficial and/or synergistically improved effect in reducing mutagenic formations, particularly in topically applied formulations. | 04-21-2016 |